Alnylam Pharmaceuticals
ALNY
#570
Rank
C$51.77 B
Marketcap
$401.40
Share price
1.16%
Change (1 day)
66.29%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: $435.27 CAD on 2024-10-16

Lowest end of day price: $5.72 CAD on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$29.30 1.40%๐Ÿ‡บ๐Ÿ‡ธ USA
$989.28-0.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$165.75-0.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.19 0.67%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.45 3.09%๐Ÿ‡บ๐Ÿ‡ธ USA
$151.71 1.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$78.42 3.84%๐Ÿ‡ซ๐Ÿ‡ท France
$25.84-3.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel